Stockreport

VivoPower Commences Strategic Share Conversion Program; Initial 2.96 Million Listed Class A Ordinary Shares Becoming Unlisted Restricted Class B Shares, Reducing Public Float

Meridian Bioscience Inc.  (VIVO) 
Last meridian bioscience inc. earnings: 2/7 07:25 am Check Earnings Report
US:NASDAQ Investor Relations: investor.meridianbioscience.com
PDF Follows recently announced share acquisitions totaling 2.65 million shares by board members, including Executive Chairman and CEO, Kevin Chin, who purchased the majority [Read more]